Sleep Apnea and Heart Disease: The Dangerous Link You Need to Know About
Untreated sleep apnea significantly raises your risk of heart attack, hypertension, and AFib.
Forty to eighty per cent of people with heart disease also have obstructive sleep apnea.
Most of them have never been tested for it.
Each time your airway closes and you stop breathing, your oxygen level drops, your adrenaline surges, and your heart is forced to work harder during what should be its recovery window. Repeat that dozens or hundreds of times a night. Repeat it every night for years.
The American Heart Association published a scientific statement in Circulation classifying OSA as a major risk factor for hypertension, coronary heart disease, heart failure, and stroke. Not a contributing factor. A major risk factor (Yeghiazarians et al., Circulation, 2021).
If your blood pressure has been difficult to control despite three or more medications, or if you have had a cardiac event, there is a meaningful chance that undiagnosed sleep apnea is part of why.
How Common Is Sleep Apnea in Heart Patients?
Among people with cardiovascular disease, the prevalence of OSA is striking. Between 40 and 80% of patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, or stroke also have obstructive sleep apnea (American Heart Association, Circulation, 2021). Despite this, OSA is "under-recognised and under-treated" in cardiac populations, in the AHA's own phrasing.
The probability is not small
If you already have heart disease, the chance that you also have OSA is not a statistical footnote. It is closer to a coin flip. In the general population, over 80% of moderate-to-severe OSA cases go undiagnosed at any given time. Among cardiac patients, the rates are similarly poor, despite the higher stakes.
What Happens to Your Heart During an Apnea Episode?
The damage from sleep apnea follows specific, documented mechanisms.
The adrenaline surge and sustained hypertension
Each apnea event triggers a cascade. The airway closes. Blood oxygen falls. The hypothalamus reads this as a crisis and fires the sympathetic nervous system. Adrenaline and noradrenaline flood the bloodstream. Blood pressure spikes. Heart rate climbs. Then breathing restarts and the values normalise. Until the next event, minutes later.
Done 30 times a night, this repeated sympathetic firing does not fully reset between episodes. Over months and years, the surges become sustained hypertension. The endothelium accumulates damage. LDL cholesterol is elevated by sleep fragmentation. Atherosclerosis accelerates. OSA is one of the most common identifiable causes of treatment-resistant hypertension. Among patients whose blood pressure does not respond to three or more antihypertensive medications, OSA is present in up to 83% (Pedrosa et al., Hypertension, 2011).
The intrathoracic pressure pathway: why OSA causes atrial fibrillation
When the upper airway closes during an apnea, the person attempts to breathe against a sealed passage. This generates extreme negative pressure inside the chest cavity, reaching -65 mmHg in some studies. The chest is not built to sustain that repetitively. This negative pressure physically stretches the left atrium. Repeated stretching causes atrial remodelling: the atrial walls change structurally, and the electrical pathways within them are disrupted. Atrial fibrillation becomes more likely.
People with untreated OSA are two to four times more likely to develop atrial fibrillation than people without OSA (Journal of the American Heart Association, 2023). Among patients who have undergone cardioversion for AFib, OSA significantly increases the rate of recurrence.
Oxidative stress and inflammation: the slower pathway
Each oxygen desaturation event triggers mitochondrial stress and the release of reactive oxygen species. Over time, repeated hypoxia activates inflammatory cytokines including TNF-alpha and interleukin-6. These promote endothelial dysfunction, increase coagulability, and drive adverse myocardial remodelling. This is a slower-acting mechanism than the adrenaline surge, but it compounds over years.
How Much Does Untreated Sleep Apnea Raise Cardiovascular Risk?
The risk elevations associated with untreated moderate-to-severe OSA are not marginal. They are clinically significant by any standard.
| Cardiovascular condition | Risk with untreated OSA | Source |
|---|---|---|
| Heart failure | +140% | AHA Scientific Statement, Circulation 2021 |
| Stroke | +60% | AHA Scientific Statement, Circulation 2021 |
| Coronary heart disease | +30% | AHA Scientific Statement, Circulation 2021 |
| Atrial fibrillation | 2–4x more likely | JAHA 2023 |
| Heart attack | 2x more likely | AHA / Harvard Health |
These are the kind of risk elevations that, if attributed to a medication, would trigger a recall. They are the consequence of a treatable breathing problem that most cardiac patients have never been tested for.
The Bidirectional Trap
Here is what no one told you: OSA makes heart disease worse, and heart disease makes OSA worse.
Untreated sleep apnea causes hypertension, inflammation, and atrial remodelling, all of which weaken the heart. A weakened heart has reduced cardiac output, which leads to fluid retention. Retained fluid redistributes when the person lies down, accumulating around the upper airway and narrowing it further. A narrower airway produces worse sleep apnea. Which causes more cardiac strain. Which causes more fluid. Which causes worse OSA.
Once this loop is established, improving only the heart medication does not break it. What breaks the loop is treating both. In most patients, treating the OSA is the accessible first step.
What we see in our sleep clinic at Respire
The patients who show the most dramatic blood pressure improvements after starting CPAP are often the ones who had been told their hypertension was simply "resistant." Among patients with resistant hypertension, OSA prevalence reaches up to 83%. Once the airway is treated, the medications that were not working begin working. Dr. Pradyut Waghray works closely with cardiologists across Hyderabad to identify this pattern before it has further time to compound cardiac risk.
Does CPAP Treatment Actually Protect Your Heart?
The evidence on CPAP and cardiovascular outcomes is real, but it requires careful framing.
When CPAP clearly helps
In patients with high-risk OSA, defined as an AHI of 30 or above, consistent CPAP use is associated with meaningful cardiovascular benefit. A 2021 analysis found approximately a 17% reduction in major adverse cardiovascular events in patients with moderate-to-severe OSA who were compliant with CPAP (four or more hours per night).
For atrial fibrillation specifically, the data are striking. Kanagala et al. (Circulation, 2003) found that patients with untreated OSA had an 82% recurrence rate of AFib after cardioversion, compared to 42% in those with treated OSA. That is a 42% reduction in AFib recurrence simply from treating the underlying sleep apnea. CPAP also lowers nocturnal blood pressure. In many patients, this effect extends into the daytime, meaningfully reducing 24-hour blood pressure in patients with previously resistant hypertension. In patients with heart failure, treating OSA with CPAP can improve left ventricular ejection fraction, a measure of how effectively the heart pumps blood, over time.
The important caveat: not everyone benefits equally
The SAVE trial (McEvoy et al., New England Journal of Medicine, 2016) studied CPAP in patients with established cardiovascular disease who did not necessarily have high-risk OSA. The trial found no reduction in major adverse cardiovascular events in this broader population. CPAP is not a heart disease treatment for everyone who has mild OSA. It is a critical intervention for people with moderate-to-severe OSA, the population at highest cardiovascular risk. Get tested. Know your AHI. If it is 15 or above, the cardiovascular case for treatment is strong.
Who Should Be Screened Because of Heart Disease?
Based on AHA and AASM guidance, the following cardiac presentations warrant a sleep apnea evaluation:
Blood pressure that does not respond to three or more antihypertensive medications (resistant hypertension)
Recurrent atrial fibrillation, particularly after cardioversion
Unexplained nocturnal arrhythmias
New-onset heart failure with reduced ejection fraction
Stroke, particularly if occurring at night or in the early morning
Pulmonary hypertension
Coronary artery disease that is poorly controlled despite medication compliance
At Respire Airway Clinics, Dr. Pradyut Waghray works closely with cardiologists in Hyderabad to ensure that cardiac patients are evaluated for OSA before their sleep problem has further time to compound their heart risk. A home-based sleep study takes one night. The result tells you and your cardiologist exactly where you stand.
Your specialists
Sleep medicine and cardiovascular co-management at Respire Airway Clinics. We work alongside cardiologists across Hyderabad to integrate sleep medicine into cardiovascular care.
Frequently asked questions
Can sleep apnea cause heart disease?
Yes. Untreated obstructive sleep apnea is an independent risk factor for hypertension, coronary artery disease, heart failure, stroke, and atrial fibrillation. The American Heart Association classifies OSA as a major risk factor for cardiovascular disease, not a minor associated condition (Yeghiazarians et al., Circulation, 2021).
How does sleep apnea affect the heart?
Sleep apnea damages the heart through three main mechanisms: repeated adrenaline surges that cause sustained hypertension and accelerate atherosclerosis; negative intrathoracic pressure during apnea events that stretches and remodels the atria, causing AFib; and oxidative stress and inflammation from repeated hypoxia that drive long-term myocardial damage.
Can sleep apnea cause atrial fibrillation?
Yes. People with untreated OSA are two to four times more likely to develop atrial fibrillation. Among patients who have undergone cardioversion for AFib, treating OSA reduces AFib recurrence by approximately 42% (Kanagala et al., Circulation, 2003). Cardiologists managing recurrent AFib should routinely screen for untreated OSA.
Does CPAP reduce the risk of heart disease?
In patients with moderate-to-severe OSA, CPAP compliance is associated with meaningful cardiovascular benefit, including reduced blood pressure, lower AFib recurrence rates, and improved cardiac function in heart failure patients. The SAVE trial found no MACE benefit in patients without high-risk OSA who had established CVD. The cardiovascular case for CPAP is strongest in patients with AHI above 15 to 30.
What percentage of heart patients have sleep apnea?
Between 40 and 80% of patients with cardiovascular disease, including hypertension, heart failure, coronary artery disease, atrial fibrillation, and stroke, also have obstructive sleep apnea (AHA, Circulation, 2021). Despite this prevalence, OSA remains under-recognised and under-treated in cardiac populations.
Is sleep apnea dangerous if you have high blood pressure?
Yes. OSA is one of the most common identifiable causes of treatment-resistant hypertension. Repeated nocturnal blood pressure surges from sympathetic activation damage the endothelium and accelerate cardiovascular risk. In patients with resistant hypertension, defined as blood pressure not controlled on three or more medications, with OSA prevalence reaches up to 83%. Treating the OSA frequently reduces blood pressure to levels where existing medication becomes effective.
Can treating sleep apnea reverse heart damage?
Treating sleep apnea does not reverse existing structural cardiac damage, such as established atherosclerosis or myocardial scarring. It does stop the ongoing damage, lower blood pressure, reduce AFib recurrence, and improve cardiac function in some patients with heart failure. The earlier OSA is identified and treated, the less accumulated cardiovascular injury occurs.
If you have heart disease, resistant hypertension, or recurrent AFib, and you have never been evaluated for sleep apnea, that gap is worth closing. A home sleep study takes one night. The result tells both you and your cardiologist exactly where things stand.
Respire Airway Clinics, Basheer Bagh and Jubilee Hills. All consultations are strictly confidential.
Reviewed by Dr. Pradyut Waghray, MBBS, MD, FRCP (London), FCCP, FAMS. Special interest in sleep-disordered breathing and comorbid cardiovascular disease.